Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 60 full-time employees. The company went IPO on 2016-06-03. The firm is engaged in the development and delivery of non-invasive treatments for non-melanoma skin cancer (NMSC) and post-surgical keloid scar prevention. The firm uses a proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is incorporated into a portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT technology is used to effectively and safely treat oncological and non-oncological skin conditions. The SRT-100 is a photon x-ray low-energy SRT system that provides patients with an alternative to surgery for treating NMSC, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with an SRT-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and comprehensive dosimetry parameters.
Quel est le ratio P/E de Sensus Healthcare Inc (SRTS) ?
Le ratio P/E de Sensus Healthcare Inc est de 9.4394
Qui est le CEO de Sensus Healthcare Inc ?
Mr. Joseph Sardano est le Chairman of the Board de Sensus Healthcare Inc, il a rejoint l'entreprise depuis 2010.
Quelle est la performance du prix de l'action SRTS ?
Le prix actuel de SRTS est de $2.71, il a 下降 de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Sensus Healthcare Inc ?
Sensus Healthcare Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Sensus Healthcare Inc ?
La capitalisation boursière actuelle de Sensus Healthcare Inc est de $44.6M
Est-ce que Sensus Healthcare Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 6 analystes ont établi des notations d'analystes pour Sensus Healthcare Inc, y compris 2 achat fort, 8 achat, 1 maintien, 0 vente et 2 vente forte